Status:
RECRUITING
Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Rare Diseases
Genetic Predisposition
Eligibility:
All Genders
Brief Summary
For the retrospective data analysis, patients with genetic diseases of any age and, if available, other family members, for whom genetic analyzes were carried out between 10/2016 and 12/2020, should b...
Detailed Description
The methodological developments of the last few years allow the broad use of next-generation-sequencing (NGS) -based methods in the routine molecular genetic diagnosis of genetic diseases.The aim of t...
Eligibility Criteria
Inclusion
- Patient with genetic disease or
- Family members
- Genetic analysis between 10/2016 and 12/2020 at the Institute for Medical Genetics and Applied Genomics at the University Hospital Tübingen
Exclusion
- \- None
Key Trial Info
Start Date :
February 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT04731857
Start Date
February 18 2021
End Date
February 1 2027
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tübingen
Tübingen, Germany, 72076